Recanalization Rate of Acute DVT

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

April 1, 2025

Study Completion Date

June 1, 2025

Conditions

Acute DVT of Lower Extremity

Interventions

DRUG

New oral anticoagulant (rivaroxaban) and Marevan (warfarin)

comparison between 2 drug, (rivaroxaban) and Marevan (warfarin)

All Listed Sponsors

lead

Assiut University

OTHER

NCT06145269 - Recanalization Rate of Acute DVT | Biotech Hunter | Biotech Hunter